Navigation Links
Dilon Diagnostics Receives ISO 13485 Certification
Date:3/2/2010

NEWPORT NEWS, Va., March 2 /PRNewswire/ -- Dilon Diagnostics, a manufacturer and supplier of high-resolution molecular imaging systems, announced today that it has received ISO 13485 certification. The certification confirms Dilon's commitment to continual improvement of products, customer satisfaction, compliance with statutory and regulatory requirements and risk management.

ISO 13485 is an internationally recognized standard system which defines the requirements for design, development, production, and distribution of medical devices. It ensures conformity with specified quality controls in the development of safe and effective medical devices.

The Dilon 6800 Gamma Camera, Dilon's cornerstone product, is a high-resolution, small field-of-view gamma camera optimized to perform Breast-Specific Gamma Imaging (BSGI). BSGI is a molecular breast imaging procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. The Dilon 6800 captures vital information by viewing the metabolic activity in the breast; it can identify lesions independent of tissue density and is capable of duplicating standard mammographic views. In addition the Dilon GammaLoc™ system, an accessory to the Dilon 6800®, is the only FDA-cleared localization device that enables gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with BSGI.

Dilon's recent distribution agreement with Philips, allows the renowned healthcare company to sell and support the Dilon products in European and key Middle Eastern markets. The partnership with the global leader in medical technology demonstrates the significant endorsement of MBI/BSGI and its continued commitment to deliver the most advanced women's health solutions worldwide.

About Dilon Diagnostics

Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

SOURCE Dilon Diagnostics

Back to top

RELATED LINKS
http://www.dilon.com

'/>"/>

SOURCE Dilon Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
2. Quest Diagnostics Unveils Care360(TM) EHR
3. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
4. Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice
5. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
6. Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays.
7. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
8. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
9. Fujirebio Diagnostics Named Life Sciences Company of the Year
10. U.S. Patent Office Issues Sword Diagnostics Patent for Highly Sensitive Immunodetection Technology
11. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Inc., a Philadelphia -based biotechnology company developing ... completion of a $12.7 million Series A financing round. The ... the participation of existing investors. ... New Ventures III and our current investors, and view the ... our platform technology to transform the course of PD and ...
Breaking Medicine Technology:
(Date:7/21/2017)... Helena, AL (PRWEB) , ... July 21, 2017 ... ... that offers insurance assistance and financial planning services to communities in the greater ... that promises to provide resources to underprivileged young people in the region. , ...
(Date:7/21/2017)... ... , ... Hospital M&A activity slowed in the second quarter of 2017, according ... to 23 in the second quarter, up 15% from the 20 publicly announced acquisitions ... in the year-ago second quarter. Only four of the transactions disclosed a purchase price ...
(Date:7/21/2017)... NJ (PRWEB) , ... July 21, 2017 , ... ... has received a $5,000 grant from the C. R. Bard Foundation, ... Day Center at Somerset Hills , a service available through the nonprofit home ...
(Date:7/21/2017)... ... , ... West Dermatology is pleased to announce the newest addition to their ... Vu will join West Dermatology’s large network of medical and cosmetic dermatology practices, bringing ... and more. She graduated from the University of Florida College of Medicine Physician Assistant ...
(Date:7/20/2017)... Viejo, CA (PRWEB) , ... July 20, 2017 , ... ... when placed between two clips in the FCPX timeline. This effect isolates horizontal and ... transition in this package contains either a rotating or flipping animation and can be ...
Breaking Medicine News(10 mins):